eli lilly phase 3 trial retatrutide just announced striking results for retatrutide, an experimental “triple agonist” that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28% Phase-3-Retatrutide-trial-sees-participants-achieve-up-to-30-weight-loss

Surv Ophthalmol

Anyone with a personal or family history of certain thyroid cancers should discuss this specifically with their prescribing physician before starting treatment

Abstract Importance: GLP-1 receptor agonists (GLP-1 RAs) are widely recognized for their antidiabetic properties, primarily due to their insulin secretagogue action

Blood glucose should be monitored closely and a medication review sought from your GP or diabetes specialist (see NICE NG28: Type 2 diabetes in adults: management)

Vomiting (the third most commonly reported side effect) Stay hydrated

However, berberine did improve blood sugar and cholesterol numbers